Chuangye Han

2.3k total citations
89 papers, 1.5k citations indexed

About

Chuangye Han is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Chuangye Han has authored 89 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 37 papers in Cancer Research and 29 papers in Oncology. Recurrent topics in Chuangye Han's work include Pancreatic and Hepatic Oncology Research (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cancer-related molecular mechanisms research (15 papers). Chuangye Han is often cited by papers focused on Pancreatic and Hepatic Oncology Research (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (17 papers) and Cancer-related molecular mechanisms research (15 papers). Chuangye Han collaborates with scholars based in China, United States and Hong Kong. Chuangye Han's co-authors include Tao Peng, Xiwen Liao, Guangzhi Zhu, Chengkun Yang, Xiangkun Wang, Tingdong Yu, Xinping Ye, Ketuan Huang, Hao Su and Wei Qin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Chuangye Han

84 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Chuangye Han China	24	790	644	407	318	196	89	1.5k
Haoming Lin China	16	1.1k 1.4×	784 1.2×	513 1.3×	237 0.7×	150 0.8×	47	1.8k
Ximing Xu China	24	896 1.1×	599 0.9×	324 0.8×	527 1.7×	114 0.6×	101	1.6k
Yun Hong China	22	693 0.9×	330 0.5×	351 0.9×	522 1.6×	180 0.9×	76	1.6k
Chenyue Zhang China	22	680 0.9×	465 0.7×	303 0.7×	578 1.8×	113 0.6×	74	1.4k
Ruipeng Song China	22	997 1.3×	651 1.0×	145 0.4×	275 0.9×	143 0.7×	51	1.7k
Changwei Dou China	22	1.2k 1.5×	852 1.3×	245 0.6×	334 1.1×	198 1.0×	46	1.8k
Zhifei Lin China	14	660 0.8×	405 0.6×	220 0.5×	313 1.0×	158 0.8×	22	1.3k
Federica Papaccio Italy	21	1.0k 1.3×	594 0.9×	293 0.7×	909 2.9×	112 0.6×	42	2.0k
Guishuai Lv China	15	1.3k 1.7×	1.0k 1.6×	180 0.4×	330 1.0×	170 0.9×	18	2.0k
Sunbin Ling China	19	790 1.0×	402 0.6×	119 0.3×	533 1.7×	265 1.4×	50	1.4k

Countries citing papers authored by Chuangye Han

Since Specialization

Citations

This map shows the geographic impact of Chuangye Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuangye Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuangye Han more than expected).

Fields of papers citing papers by Chuangye Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuangye Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuangye Han. The network helps show where Chuangye Han may publish in the future.

Co-authorship network of co-authors of Chuangye Han

This figure shows the co-authorship network connecting the top 25 collaborators of Chuangye Han. A scholar is included among the top collaborators of Chuangye Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuangye Han. Chuangye Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, He, Ziyan Lu, Meifeng Chen, et al.. (2025). Comprehensive Pan-Cancer Analysis and Functional Studies Reveal SLC2A6 as a Ferroptosis Modulator in Hepatocellular carcinoma. Scientific Reports. 15(1). 2545–2545. 1 indexed citations

Gao, Qiang, Ketuan Huang, Yuan Liao, et al.. (2025). Artificial intelligence algorithm was used to establish and verify the prediction model of portal hypertension in hepatocellular carcinoma based on clinical parameters and imaging features. Journal of Gastrointestinal Oncology. 16(1). 159–175.

Han, Chuangye, et al.. (2025). Atorvastatin negatively regulates MAPK pathway in vitro to inhibit proliferation, migration, and invasion of hepatocellular carcinoma cells. Scientific Reports. 15(1). 41279–41279.

Han, Chuangye, et al.. (2024). Advancements in programmed cell death research in antitumor therapy: a comprehensive overview. APOPTOSIS. 30(1-2). 401–421. 7 indexed citations

Chen, Liang, Meifeng Chen, Yan Xie, et al.. (2024). 2‐dodecyl‐6‐methoxycyclohexa‐2,5‐diene‐1,4‐dione mediates the effect of ROS ‐enhanced PI3K /Akt/ mTOR pathway on autophagy in breast cancer. FEBS Open Bio. 15(3). 474–489.

Liao, Xiwen, et al.. (2023). Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report. Pharmacogenomics and Personalized Medicine. Volume 16. 111–120. 1 indexed citations

Liao, Xiwen, Xin Zhou, Chuangye Han, et al.. (2023). PUS1 May Be a Potential Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma. Pharmacogenomics and Personalized Medicine. Volume 16. 337–355. 8 indexed citations

Gao, Qiang, Guangzhi Zhu, Chuangye Han, et al.. (2023). Dual transformation therapy for giant hepatocellular carcinoma: Two case reports and review of literature. World Journal of Gastrointestinal Surgery. 15(9). 2089–2097. 1 indexed citations

Zhou, Xin, Junqi Liu, Chuangye Han, et al.. (2023). Sarcosine dehydrogenase as an immune infiltration-associated biomarker for the prognosis of hepatocellular carcinoma. Journal of Cancer. 15(1). 149–165. 4 indexed citations

10.

Huang, Huasheng, Xiwen Liao, Guangzhi Zhu, et al.. (2022). Acyl-CoA Binding Domain Containing 4 Polymorphism rs4986172 and Expression Can Serve as Overall Survival Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Patients After Hepatectomy. SHILAP Revista de lepidopterología. 7 indexed citations

11.

Yang, Chengkun, Xiwen Liao, Xin Zhou, et al.. (2022). High-Mobility Group AT-Hook 1 Served as a Prognosis Biomarker and Associated with Immune Infiltrate in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. 8 indexed citations

12.

Zhu, Yu, Wenlong Cao, Chuangye Han, et al.. (2022). Biomimetic Metal-Organic Framework Nanoparticles for Synergistic Combining of SDT-Chemotherapy Induce Pyroptosis in Gastric Cancer. Frontiers in Bioengineering and Biotechnology. 10. 796820–796820. 49 indexed citations

13.

Zhu, Guangzhi, Hao Su, Chuangye Han, et al.. (2022). A novel Peng’s test in reducing bile leakage after partial hepatectomy for hepatocellular carcinoma: From an animal study to a clinical cohort Propensity score matching comparative study. International Journal of Surgery. 104. 106748–106748. 4 indexed citations

14.

Fang, Dalang, Zijun Chen, Shuqi Zhao, et al.. (2021). Laparoscopic versus open hepatectomy for hepatocellular carcinoma with cirrhosis: a single-center propensity score matching analysis. Annals of Translational Medicine. 9(23). 1733–1733. 1 indexed citations

15.

Qin, Wei, Chuangye Han, Rongyun Mai, et al.. (2020). Establishment of a prognostic model for predicting short-term disease-free survival in cases of hepatitis B-related hepatocellular carcinoma with the TP53 249Ser mutation in southern China. Translational Cancer Research. 9(8). 4517–4533. 7 indexed citations

16.

Liu, Junqi, Xiwen Liao, Xiangkun Wang, et al.. (2020). Prognostic value of Glypican family genes in early-stage pancreatic ductal adenocarcinoma after pancreaticoduodenectomy and possible mechanisms. BMC Gastroenterology. 20(1). 415–415. 13 indexed citations

17.

Han, Chuangye, Tingdong Yu, Wei Qin, et al.. (2020). Genome-wide association study of the TP53 R249S mutation in hepatocellular carcinoma with aflatoxin B1 exposure and infection with hepatitis B virus. Journal of Gastrointestinal Oncology. 11(6). 1333–1349. 18 indexed citations

18.

Liao, Xiwen, Xiaoguang Liu, Chengkun Yang, et al.. (2018). Distinct Diagnostic and Prognostic Values of Minichromosome Maintenance Gene Expression in Patients with Hepatocellular Carcinoma. Journal of Cancer. 9(13). 2357–2373. 52 indexed citations

19.

Zhao, Guo-Liang, Chuangye Han, Zhi Zhang, Lei Wang, & Jing Xu. (2017). Increased expression of microRNA-31-5p inhibits cell proliferation, migration, and invasion via regulating Sp1 transcription factor in HepG2 hepatocellular carcinoma cell line. Biochemical and Biophysical Research Communications. 490(2). 371–377. 41 indexed citations

20.

Han, Chuangye, Xiwen Liao, Wei Qin, et al.. (2016). EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma. Scientific Reports. 6(1). 31237–31237. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact